1,3-dipropyl-8-cyclopentylxanthine has been researched along with thyroxine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Branzaniuc, K; Galajda, Z; Gesztelyi, R; Kiss, Z; Pak, K; Papp, C; Szentmiklosi, AJ; Tosaki, A; Zsuga, J | 1 |
1 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and thyroxine
Article | Year |
---|---|
Thyroid hormones decrease the affinity of 8-cyclopentyl-1,3-dipropylxanthine (CPX), a competitive antagonist, for the guinea pig atrial A(1) adenosine receptor.
Topics: Animals; Drug Synergism; Guinea Pigs; Heart Atria; Male; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A1; Thyroxine; Treatment Outcome; Xanthines | 2012 |